UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chemically Defined Antibody– and Small Molecule–Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis

Journal of the American Chemical Society, 2018-02, Vol.140 (5), p.1617-1621

2018

Volltextzugriff (PDF)

Versatile protein recognition by the encoded display of multiple chemical elements on a constant macrocyclic scaffold

Nature chemistry, 2018-04, Vol.10 (4), p.441-448

2018

Volltextzugriff (PDF)

Enhanced Therapeutic Activity of Non-Internalizing Small-Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX in Combination with Targeted Interleukin-2

Clinical cancer research, 2018-08, Vol.24 (15), p.3656-3667

2018

Volltextzugriff (PDF)

An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications

Proceedings of the National Academy of Sciences - PNAS, 2021-04, Vol.118 (16), p.1-10

2021

Volltextzugriff (PDF)

Stereo- and regiodefined DNA-encoded chemical libraries enable efficient tumour-targeting applications

Nature chemistry, 2021-06, Vol.13 (6), p.540-548

2021

Volltextzugriff (PDF)

Protease-Cleavable Linkers Modulate the Anticancer Activity of Noninternalizing Antibody–Drug Conjugates

Bioconjugate chemistry, 2017-07, Vol.28 (7), p.1826-1833

2017

Volltextzugriff (PDF)

An Attenuated Targeted-TNF Localizes to Tumors In Vivo and Regains Activity at the Site of Disease

International journal of molecular sciences, 2021-09, Vol.22 (18), p.10020

2021

Volltextzugriff (PDF)

Targeted Delivery of Cytotoxic Drugs: Challenges, Opportunities and New Developments

Chimia, 2017-10, Vol.71 (10), p.712

2017

Volltextzugriff (PDF)

Publisher Correction: Stereo- and regiodefined DNA-encoded chemical libraries enable efficient tumour-targeting applications

Nature chemistry, 2021-07, Vol.13 (7), p.714-714

2021

Volltextzugriff (PDF)

Ex vivo mass spectrometry-based biodistribution analysis of an antibody-Resiquimod conjugate bearing a protease-cleavable and acid-labile linker

Frontiers in pharmacology, 2023-12, Vol.14, p.1320524-1320524

2023

Volltextzugriff (PDF)

Automated Radiosynthesis, Preliminary In Vitro/In Vivo Characterization of OncoFAP-Based Radiopharmaceuticals for Cancer Imaging and Therapy

Pharmaceuticals (Basel, Switzerland), 2022-08, Vol.15 (8), p.958

2022

Volltextzugriff (PDF)

Sortase-Mediated Site-Specific Modification of Interleukin‑2 for the Generation of a Tumor-Targeting Acetazolamide–Cytokine Conjugate

ACS omega, 2020-10, Vol.5 (40), p.26077-26083

2020

Volltextzugriff (PDF)

In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas

ACS omega, 2018-11, Vol.3 (11), p.14726-14731

2018

Volltextzugriff (PDF)

Deep Learning Approach for the Discovery of Tumor-Targeting Small Organic Ligands from DNA-Encoded Chemical Libraries

ACS omega, 2023-07, Vol.8 (28), p.25090-25100

2023

Volltextzugriff (PDF)

Acetazolamide Serves as Selective Delivery Vehicle for Dipeptide-Linked Drugs to Renal Cell Carcinoma

Molecular cancer therapeutics, 2016-12, Vol.15 (12), p.2926-2935

2016

Volltextzugriff (PDF)

Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma

Journal of controlled release, 2017-01, Vol.246, p.39-45

2017

Volltextzugriff (PDF)

A Dimeric FAP-Targeting Small-Molecule Radioconjugate with High and Prolonged Tumor Uptake

Journal of Nuclear Medicine, 2022-12, Vol.63 (12), p.1852-1858

2022

Volltextzugriff (PDF)

In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma

ACS omega, 2018-12, Vol.3 (12), p.16743-16743

2018

Volltextzugriff (PDF)

Molecular Evolution of Multivalent OncoFAP Derivatives with Enhanced Tumor Uptake and Prolonged Tumor Retention

Journal of medicinal chemistry, 2024-08, Vol.67 (15), p.13392-13408

2024

Volltextzugriff (PDF)

Preclinical Evaluation of 177 Lu-OncoFAP-23, a Multivalent FAP-Targeted Radiopharmaceutical Therapeutic for Solid Tumors

Journal of Nuclear Medicine, 2024-10, Vol.65 (10), p.1604-1610

2024

Volltextzugriff (PDF)

Cytokine Biopharmaceuticals with “Activity-on-Demand” for Cancer Therapy

Bioconjugate chemistry, 2024-08, Vol.35 (8), p.1075-1088

2024

Volltextzugriff (PDF)

Targeted interleukin-2 enhances the in vivo anti-cancer activity of Pluvicto

European journal of nuclear medicine and molecular imaging, 2024-07, Vol.51 (8), p.2332-2337

2024

Volltextzugriff (PDF)

Mass Spectrometry-Based Method for the Determination of the Biodistribution of Tumor-Targeting Small Molecule–Metal Conjugates

Analytical chemistry (Washington), 2022-08, Vol.94 (30), p.10715-10721

2022

Volltextzugriff (PDF)

Discovery of Glutamate Carboxypeptidase III Ligands to Compete the Uptake of [177Lu]Lu-PSMA-617 in Healthy Organs

Journal of medicinal chemistry, 2024-05, Vol.67 (10), p.8247-8260

2024

Volltextzugriff (PDF)

Response to: GCP III is not the “off-target” for urea-based PSMA-ligands

European journal of nuclear medicine and molecular imaging, 2023-08, Vol.50 (10), p.2947-2949

2023

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(60)
Buchkapitel
(1)

Sprache

Englisch
(61)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Chemically Defined Antibody– and Small Molecule–Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis

Versatile protein recognition by the encoded display of multiple chemical elements on a constant macrocyclic scaffold

Enhanced Therapeutic Activity of Non-Internalizing Small-Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX in Combination with Targeted Interleukin-2

An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications

Stereo- and regiodefined DNA-encoded chemical libraries enable efficient tumour-targeting applications

Protease-Cleavable Linkers Modulate the Anticancer Activity of Noninternalizing Antibody–Drug Conjugates

An Attenuated Targeted-TNF Localizes to Tumors In Vivo and Regains Activity at the Site of Disease

Targeted Delivery of Cytotoxic Drugs: Challenges, Opportunities and New Developments

Publisher Correction: Stereo- and regiodefined DNA-encoded chemical libraries enable efficient tumour-targeting applications

Ex vivo mass spectrometry-based biodistribution analysis of an antibody-Resiquimod conjugate bearing a protease-cleavable and acid-labile linker

Automated Radiosynthesis, Preliminary In Vitro/In Vivo Characterization of OncoFAP-Based Radiopharmaceuticals for Cancer Imaging and Therapy

Sortase-Mediated Site-Specific Modification of Interleukin‑2 for the Generation of a Tumor-Targeting Acetazolamide–Cytokine Conjugate

In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas

Deep Learning Approach for the Discovery of Tumor-Targeting Small Organic Ligands from DNA-Encoded Chemical Libraries

Acetazolamide Serves as Selective Delivery Vehicle for Dipeptide-Linked Drugs to Renal Cell Carcinoma

Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma

A Dimeric FAP-Targeting Small-Molecule Radioconjugate with High and Prolonged Tumor Uptake

In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma

Molecular Evolution of Multivalent OncoFAP Derivatives with Enhanced Tumor Uptake and Prolonged Tumor Retention

Preclinical Evaluation of 177 Lu-OncoFAP-23, a Multivalent FAP-Targeted Radiopharmaceutical Therapeutic for Solid Tumors

Cytokine Biopharmaceuticals with “Activity-on-Demand” for Cancer Therapy

Targeted interleukin-2 enhances the in vivo anti-cancer activity of Pluvicto

Mass Spectrometry-Based Method for the Determination of the Biodistribution of Tumor-Targeting Small Molecule–Metal Conjugates

Discovery of Glutamate Carboxypeptidase III Ligands to Compete the Uptake of [177Lu]Lu-PSMA-617 in Healthy Organs

Response to: GCP III is not the “off-target” for urea-based PSMA-ligands

Suchergebnisse filtern